Clinical Trial Update: A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal Cancer [Phase 1]

View source ↗

Summary

A multi-center Phase 1 study evaluates escalating doses of veliparib in combination with capecitabine and radiation for locally advanced rectal cancer; the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Veliparib (veliparib)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Locally Advanced Rectal Cancer | Phase 1 | Status: COMPLETED